Formatech Inc

Fraxa Research Foundation, based in Newburyport, MA, is dedicated to finding effective treatments and ultimately a cure for Fragile X syndrome, the most common inherited cause of autism and intellectual disabilities. The foundation funds groundbreaking research and clinical trials by partnering with top universities and biomedical companies worldwide, driven by a personal commitment from its staff and board, many of whom are parents of children affected by Fragile X. With a focus on advancing scientific understanding, Fraxa supports various research initiatives, including studies on the NMDA receptor and muscle function in children with Fragile X. The foundation has awarded numerous research grants and collaborates with pharmaceutical partners to bridge the gap between discovery and treatment, aiming to improve the lives of those impacted by Fragile X and related disorders. Generated from the website

Political Research Associates is an organization based in Somerville, MA, dedicated to providing in-depth analysis and research on political issues. They focus on promoting social justice and understanding the dynamics of power in society. With a commitment to fostering informed public discourse, Political Research Associates aims to equip individuals and organizations with the knowledge necessary to challenge oppressive systems. Their work emphasizes the importance of modern tools and methodologies in political research and advocacy. Generated from the website

Ra Pharmaceuticals Inc, based in Cambridge, MA, is a global biopharmaceutical leader dedicated to creating valuable solutions that improve the lives of individuals living with neurological and autoimmune conditions. The company emphasizes innovation as a key driver of progress in healthcare, striving to deliver effective treatments for severe diseases. In addition to its commitment to advancing medical science, Ra Pharmaceuticals is focused on sustainability and positively impacting society while supporting communities and protecting the planet for future generations. The company also invests in pioneering technologies through UCB Ventures, aiming to transform the lives of patients worldwide. Generated from the website